Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13723022 | 0.83 | HTT (0.44) | — | |
| SCHEMBL3297054 | 0.81 | IDO1 (0.38) | CYP4F2CYP4A11FFAR1FFAR4CA1 | |
| SCHEMBL19199493 | 0.77 | ATR (0.40) | — | |
| SCHEMBL19220255 | 0.76 | LMNA (0.35) | CYP4F2CYP4A11 | |
| SCHEMBL19220492 | 0.76 | TSHR (0.39) | FFAR1FFAR4 | |
| SCHEMBL15473474 | 0.74 | NR3C1 (0.38) | FFAR1FFAR4CA1CA2 | |
| SCHEMBL14785048 | 0.74 | IDO1 (0.33) | FFAR1FFAR4CA1CA2 | |
| SCHEMBL19194465 | 0.73 | CYP4F2 (0.31) | CYP4F2CYP4A11 | |
| SCHEMBL3242505 | 0.71 | HTT (0.50) | — | |
| SCHEMBL14060654 | 0.70 | CYP19A1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9902716-B2 | Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-02-27 | — | — | US | disclosed |
| US-20170226092-A1 | FLUORINATED BENZOFURANYL-PYRIMIDINE DERIVATIVES CONTAINING A SUFLONE GROUP | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226092-A1 | FLUORINATED BENZOFURANYL-PYRIMIDINE DERIVATIVES CONTAINING A SUFLONE GROUP | FANCF, FLI1, FANCD2 | CYP4F2 132/4885CYP4A11 1253/4885FFAR1 376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.